These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 14612499
1. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK. Cancer Res; 2003 Nov 01; 63(21):7081-8. PubMed ID: 14612499 [Abstract] [Full Text] [Related]
2. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E, Mills GB, Tsang BK. Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739 [Abstract] [Full Text] [Related]
3. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells]. Yang XK, Wang JD, Wang SY, Zhang YX. Zhonghua Zhong Liu Za Zhi; 2008 Apr 01; 30(4):259-62. PubMed ID: 18788627 [Abstract] [Full Text] [Related]
4. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Yang X, Fraser M, Moll UM, Basak A, Tsang BK. Cancer Res; 2006 Mar 15; 66(6):3126-36. PubMed ID: 16540663 [Abstract] [Full Text] [Related]
5. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function. Fraser M, Bai T, Tsang BK. Int J Cancer; 2008 Feb 01; 122(3):534-46. PubMed ID: 17918180 [Abstract] [Full Text] [Related]
6. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D. Gynecol Oncol; 2005 May 01; 97(2):413-21. PubMed ID: 15863139 [Abstract] [Full Text] [Related]
7. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y. Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518 [Abstract] [Full Text] [Related]
8. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel. Mitsuuchi Y, Johnson SW, Selvakumaran M, Williams SJ, Hamilton TC, Testa JR. Cancer Res; 2000 Oct 01; 60(19):5390-4. PubMed ID: 11034077 [Abstract] [Full Text] [Related]
9. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Cancer Res; 2000 Oct 15; 60(20):5659-66. PubMed ID: 11059757 [Abstract] [Full Text] [Related]
10. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gagnon V, Mathieu I, Sexton E, Leblanc K, Asselin E. Gynecol Oncol; 2004 Sep 15; 94(3):785-95. PubMed ID: 15350374 [Abstract] [Full Text] [Related]
11. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ. Cancer Lett; 2010 Sep 01; 295(1):110-23. PubMed ID: 20236757 [Abstract] [Full Text] [Related]
12. Aurora-A induces cell survival and chemoresistance by activation of Akt through a p53-dependent manner in ovarian cancer cells. Yang H, He L, Kruk P, Nicosia SV, Cheng JQ. Int J Cancer; 2006 Nov 15; 119(10):2304-12. PubMed ID: 16894566 [Abstract] [Full Text] [Related]
13. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E. Apoptosis; 2008 Feb 15; 13(2):259-71. PubMed ID: 18071906 [Abstract] [Full Text] [Related]
14. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas. Song K, Li Z, Seth P, Cowan KH, Sinha BK. Oncol Res; 1997 Feb 15; 9(11-12):603-9. PubMed ID: 9563008 [Abstract] [Full Text] [Related]
15. [Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells]. Zhou Y, Wang SY, Yang XK, Wang HM. Zhonghua Zhong Liu Za Zhi; 2011 Feb 15; 33(2):97-100. PubMed ID: 21575475 [Abstract] [Full Text] [Related]
16. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Yan X, Fraser M, Qiu Q, Tsang BK. Gynecol Oncol; 2006 Aug 15; 102(2):348-55. PubMed ID: 16545436 [Abstract] [Full Text] [Related]
17. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways]. Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ. Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 15; 45(9):691-8. PubMed ID: 21092551 [Abstract] [Full Text] [Related]
18. Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein. Abedini MR, Muller EJ, Bergeron R, Gray DA, Tsang BK. Oncogene; 2010 Jan 07; 29(1):11-25. PubMed ID: 19802016 [Abstract] [Full Text] [Related]
19. HtrA1 Down-regulation Induces Cisplatin Resistance in Colon Cancer by Increasing XIAP and Activating PI3K/Akt Pathway. Xiong Z, Fu Z, Shi J, Jiang X, Wan H. Ann Clin Lab Sci; 2017 May 07; 47(3):264-270. PubMed ID: 28667026 [Abstract] [Full Text] [Related]
20. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Puca R, Nardinocchi L, Pistritto G, D'Orazi G. Gynecol Oncol; 2008 Jun 07; 109(3):403-10. PubMed ID: 18395248 [Abstract] [Full Text] [Related] Page: [Next] [New Search]